Landscape Capital Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-40,000
Closed -$658K 637
2025
Q2
$658K Hold
40,000
0.05% 405
2025
Q1
$728K Buy
40,000
+6,084
+18% +$174K 0.06% 352
2024
Q4
$1.26M Hold
33,916
0.13% 213
2024
Q3
$1.09M Hold
33,916
0.11% 248
2024
Q2
$2.78M Hold
33,916
0.24% 130
2024
Q1
$4.91M Sell
33,916
-1,084
-3% -$91.5K 0.43% 66
2023
Q4
$3.22M Buy
35,000
+10,000
+40% +$1.02M 0.29% 84
2023
Q3
$4.13M Hold
25,000
0.55% 46
2023
Q2
$1.58M Hold
25,000
0.21% 87
2023
Q1
$849K Sell
25,000
-2,592
-9% -$135K 0.12% 145
2022
Q4
$1.59M Buy
27,592
+12,907
+88% +$797K 0.23% 85
2022
Q3
$1.38M Buy
14,685
+4,358
+42% +$620K 0.18% 107
2022
Q2
$2.3M Buy
10,327
+2,164
+27% +$725K 0.31% 65
2022
Q1
$4.49M Buy
8,163
+2,484
+44% +$1.5M 0.57% 45
2021
Q4
$3.75M Buy
5,679
+886
+18% +$677K 0.53% 49
2021
Q3
$4.02M Buy
4,793
+2,025
+73% +$2.05M 0.56% 48
2021
Q2
$3.51M Buy
2,768
+1,561
+129% +$1.76M 0.43% 62
2021
Q1
$1.32M Buy
+1,207
New +$1.59M 0.21% 84
2020
Q2
Sell
-7,037
Closed -$2.46M 359
2020
Q1
$2.46M Sell
7,037
-10,221
-59% -$7.24M 0.26% 82
2019
Q4
$10.8M Sell
17,258
-1,342
-7% -$656K 0.79% 8
2019
Q3
$6.24M Buy
+18,600
New +$5.96M 0.46% 48
2018
Q2
Sell
-4,556
Closed -$666K 529
2018
Q1
$666K Buy
+4,556
New +$771K 0.05% 274

Other funds holding CDLX

Landscape Capital Management's CDLX Position: Q3 2025 in Review

Landscape Capital Management sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 40,000 shares — an estimated $658K sold.

Landscape Capital Management first reported a position in CDLX in Q1 2018 and held it in 22 quarters. The position peaked at $10.8M in Q4 2019. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

  • Landscape Capital Management reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
  • Landscape Capital Management sold 40,000 Cardlytics shares in Q3 2025, an estimated $658K.
  • Landscape Capital Management first reported a position in Cardlytics in Q1 2018 and held it in 22 quarters.
  • Landscape Capital Management's Cardlytics position peaked at $10.8M in Q4 2019.
  • 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on Landscape Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.